To determine whether NPY may be involved in human hepatic diseases with fibrosis, Dai and colleagues measured the amount of NPY in the serum of healthy volunteers and patients diagnosed with fibrotic liver diseases, such as liver cirrhosis and hepatocellular carcinoma. Here, NPY is linked to liver disorder.